Patient characteristics
. | Case 1 . | Case 2 . | Case 3 . | Case 4 . | Case 5 . |
|---|---|---|---|---|---|
| Age, y | 46 | 41 | 47 | 48 | 56 |
| Imatinib treatment status, before/after (day from start) | |||||
| Absolute eosinophil count, 109/L | 31.5/6.5 (8) | 12.5/1.8 (7) | 10.5/0.4 (30) | 10/0.50 (30) | 9.50/2.8 (30) |
| Left ventricular ejection fraction, % | 52/28 (8) | 61/20 (7) | 59/58 (30) | 64/63 (30) | 59/60 (30) |
| Troponin level, ng/mL | > 0.02/> 0.02 (60) | < 0.02/> 0.02 (3) | < 0.02/< 0.02 (7) | < 0.02/< 0.02 (7) | < 0.02/< 0.02 (7) |
| < 0.02 (15) |
. | Case 1 . | Case 2 . | Case 3 . | Case 4 . | Case 5 . |
|---|---|---|---|---|---|
| Age, y | 46 | 41 | 47 | 48 | 56 |
| Imatinib treatment status, before/after (day from start) | |||||
| Absolute eosinophil count, 109/L | 31.5/6.5 (8) | 12.5/1.8 (7) | 10.5/0.4 (30) | 10/0.50 (30) | 9.50/2.8 (30) |
| Left ventricular ejection fraction, % | 52/28 (8) | 61/20 (7) | 59/58 (30) | 64/63 (30) | 59/60 (30) |
| Troponin level, ng/mL | > 0.02/> 0.02 (60) | < 0.02/> 0.02 (3) | < 0.02/< 0.02 (7) | < 0.02/< 0.02 (7) | < 0.02/< 0.02 (7) |
| < 0.02 (15) |
All cases were men.